Filter posts

Rare Disease Drug Development Increases but Challenges Remain

In a recent study published by Tufts University, researchers found that rare disease drug development …

Greenwood: A Critical Medicare Policy Has Been Delayed. Let’s Use This Opportunity to Get It Right...

In a piece for Morning Consult, BIO’s Jim Greenwood writes that while CAR-T cell therapies …

A Sustainable Movement to Curb Cancer in Africa

In just two years, BIO Ventures for Global Health (BVGH) has made significant progress in …

New BIO White Paper: Incorporating Real-World Evidence Within the Label of an FDA-Approved Drug

In today’s increasingly connected world, health care researchers have access to previously unimaginable troves of …

Health security threats are real: What is Congress doing?

In a rare show of bipartisan agreement, Congress recently passed and yesterday President Trump signed into …

The DISARM Act Can Help Fix the Broken Antibiotics Market

In a recent piece for Bloomberg, reporter Robert Langreth paints a harrowing picture of the quickly …

The Future of Biotech Innovation in Brazil: Improving Patient Outcomes

The 2019 BIO International Convention took place this month in Philadelphia, Pennsylvania, and featured an …

AI Helps Unravel Mystery of Neurological Disorders

Neurological disorders are estimated to affect up to 1 billion people around the world—including nearly …

BIO 2019 Wraps Up in Philadelphia

“The world is beginning to grasp that we’ve entered the dawn of a golden age …

#BIO2019: The State of the Vaccine Industry: Stimulating Sustainable Growth

There’s little doubt that vaccines are one of the most important medical advances ever created. …